2010Yunnan Journal of Traditional Chinese Medicine and Materia MedicaRequires access

Experimental Study on the Anti-HBV Activity in Vitro of Ganbikang Capsules

Yanjing Li

Open publisher page 0 citations

Abstract

Objective: To observe the inhibition effect of Ganbikang capsules on the anti-HBV activity in vitro.Methods: HepG 2.2.15 cells culture and MTT colorimetric method were used to test the drug toxicity on cells.PCR was used to test HBV DNA,ELISA to test content of HBsAg and HBeAg to study the toxicity of Ganbikang capsules on the cells,the expression of HBsAg and HBeAg and the effect of HBV-DNA.Results: TC50 of Ganbikang capsules was 4.677 mg/mL,with 0.118 mg/mL of 0% non toxicity(TC0).The copy number of HBV DNA of each group in the cells decreased after the treatment in 72 and 144 h whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in the cell culture significantly lowered whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in medicinal serum significantly lowered after the treatment in 72 and 144 h whereas the largest dose group showed the highest inhibition rate.Anti-HBV effect was obvious.TI was averagely larger than 2.Conclusion: The experiment of Ganbikang capsules on the anti-HBV activity in vitro shows strong anti-HBV effect and low toxicity.

About this research paper

What this paper is about

Objective: To observe the inhibition effect of Ganbikang capsules on the anti-HBV activity in vitro.Methods: HepG 2.2.15 cells culture and MTT colorimetric method were used to test the drug toxicity on cells.PCR was used to test HBV DNA,ELISA to test content of HBsAg and HBeAg to study the toxicity of Ganbikang capsules on the cells,the expression of HBsAg and HBeAg and the effect of HBV-DNA.Results: TC50 of Ganbikang capsules was 4.677 mg/mL,with 0.118 mg/mL of 0% non toxicity(TC0).The copy number of HBV DNA of each group in the cells decreased after the treatment in 72 and 144 h whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in the cell culture significantly lowered whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in medicinal serum significantly lowered after the treatment in 72 and 144 h whereas the largest dose group showed the highest inhibition rate.Anti-HBV effect was obvious.TI was averagely larger than 2.Conclusion: The experiment of Ganbikang capsules on the anti-HBV activity in vitro shows strong anti-HBV effect and low toxicity.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the inhibition effect of Ganbikang capsules on the anti-HBV activity in vitro.Methods: HepG 2.2.15 cells culture and MTT colorimetric method were used to test the drug toxicity on cells.PCR was used to test HBV DNA,ELISA to test content of HBsAg and HBeAg to study the toxicity of Ganbikang capsules on the cells,the expression of HBsAg and HBeAg and the effect of HBV-DNA.Results: TC50 of Ganbikang capsules was 4.677 mg/mL,with 0.118 mg/mL of 0% non toxicity(TC0).The copy number of HBV DNA of each group in the cells decreased after the treatment in 72 and 144 h whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in the cell culture significantly lowered whereas Ganbikang capsules showed the highest inhibition rate at 0.1 mg/mL.HBsAg and HBeAg concentration in medicinal serum significantly lowered after the treatment in 72 and 144 h whereas the largest dose group showed the highest inhibition rate.Anti-HBV effect was obvious.TI was averagely larger than 2.Conclusion: The experiment of Ganbikang capsules on the anti-HBV activity in vitro shows strong anti-HBV effect and low toxicity.

Key concepts: HBeAg, HBsAg, Toxicity, In vitro, Hepatitis B virus, Pharmacology, Chemistry, Growth inhibition

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental Study on the Anti-HBV Activity in Vitro of Ganbikang Capsules — Research Paper | ScholarLens